Exchange: NASDAQ·Updated 07:30 PM EST

AUTL News

News
all
press releases
Autolus Therapeutics plc 2026 Q3 - Results - Earnings Call Presentation
Autolus Therapeutics plc 2026 Q3 - Results - Earnings Call Presentation...
SeekingAlpha
Autolus Therapeutics plc 2026 Q3 - Results - Earnings Call Presentation
Autolus Therapeutics plc 2026 Q3 - Results - Earnings Call Presentation...
SeekingAlpha
More News
Autolus Therapeutics (AUTL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
Autolus Therapeutics (AUTL) Grants Inducement Awards to New Employees...
Yahoo! Finance: News
Oncology innovation is reshaping cancer care as AI, immunotherapy and targeted therapies fuel pipeline growth and spotlight promising cancer-focused stocks.
Zacks
After losing some value lately, a hammer chart pattern has been formed for Autolus Therapeutics (AUTL), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Zacks
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
Zacks
Autolus Therapeutics Q1 Earnings Call Highlights...
Yahoo! Finance: News
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL - Free Report) - Stock analysts at HC Wainwright dropped their Q2 2026 earnings estimates for shares of Autolus Therapeutics in a note issued to investors on Thursday, April 30th. HC Wainwright analyst E. Bodnar now anticipates that the company wil...
MarketBeat
Shares of Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the nine ratings firms that are covering the company...
MarketBeat
Jefferies Financial Group raised Autolus Therapeutics to a "strong-buy" rating in a report on Monday...
MarketBeat

Advertisement|Remove ads.